<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47028032Alogliptin Benzoate 850649-62-6

    Alogliptin Benzoate 850649-62-6

    簡要描述:Alogliptin Benzoate 850649-62-6
    Alogliptin Benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

    • 產(chǎn)品型號:abs47028032
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時間:2026-01-14
    • 訪  問  量:658

    詳細介紹

    品牌absinCAS850649-62-6
    分子式C25H27N5O4純度99%
    分子量461.51貨號abs47028032
    規(guī)格5mg供貨周期現(xiàn)貨
    主要用途is a potent, selective inhibitor of DPP應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    Alogliptin Benzoate 850649-62-6

    產(chǎn)品描述
    描述

    Alogliptin Benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

    純度
    99%
    儲存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    可溶性/溶解性
    200 mM in DMSO
    生物活性
    靶點
    DPP-4
    In vitro(體外研究)
    Alogliptin(SYR-322) is a potent inhibitor of DPP-4 and exhibits greater than 10,000 fold selectivity over the closely related serine proteases DPP-8 and DPP-9. Alogliptin is not an inhibitor of CYP-450 enzymes and does not block the hERG channel at concentrations up to 30 μM.
    In vivo(體內(nèi)研究)
    Alogliptin(SYR-322) produces dose-dependent improvements in glucose tolerance and increases plasma insulin levels in female Wistar fatty rats. Acute administration of alogliptin results in a significant decrease in plasma DPP-4 activity, and increases plasma active GLP-1. Alogliptin improves glucose tolerance at a dose of 0.3 mg/kg and higher, with a dose-dependent increase in plasma IRI, suggesting that improved glucose tolerance results from the ability of alogliptin to enhance insulin secretion.
    參考文獻
    參考文獻
    • 1. Feng J, et al. J Med Chem, 2007, 50(10), 2297-2300.

    • 2. Asakawa T, et al. Life Sci, 2009, 85(3-4), 122-126.

    研究領(lǐng)域
    研究領(lǐng)域
    CancerCancer MetabolismResponse to hypoxia
    Proteolysis / UbiquitinProteolytic enzymesSerine proteaseDPPs
    ImmunologyAdaptive ImmunityB CellsCD
    ImmunologyAdaptive ImmunityT CellsCD
    ImmunologyCell Type MarkersCDAdhesion
    ImmunologyCell Type MarkersCDNon-lineage
    ImmunologyImmune System DiseasesAntiviral SignalingHIV-related
    MetabolismPathways and ProcessesMetabolism processesHypoxia
    MicrobiologyOrganismVirusDNA VirusssRNA positive strand virusSARS Coronavirus
    Stem CellsHematopoietic ProgenitorsLymphoidB Lymphocytic Lineage
    Stem CellsHematopoietic ProgenitorsLymphoidT Lymphocytic Lineage
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    Alogliptin Benzoate 850649-62-6溫馨提示:本產(chǎn)品僅作科研實驗使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細地址:

    • 補充說明:

    • 驗證碼:

      請輸入計算結(jié)果(填寫阿拉伯數(shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號了解更多信息:
    歡迎您關(guān)注我們的微信公眾號
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    97色大香蕉| 亚洲日韩日韩人兽在线 | 超碰成人福利 | 黄色一级片A | 人人燥狠狠干 |